Anupam Chem Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 3.17 M
as on 15-06-2024
- Company Age 40 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 15-06-2024
- Revenue 130.43%
(FY 2023)
- Profit 188.00%
(FY 2023)
- Ebitda -52.12%
(FY 2023)
- Net Worth 10.86%
(FY 2023)
- Total Assets 12.40%
(FY 2023)
About Anupam Chem Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.17 M.
The company currently has active open charges totaling ₹8.00 Cr.
Yashita Tripathi and Seema Tripathi serve as directors at the Company.
- CIN/LLPIN
U93000DL1984PTC017594
- Company No.
017594
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 1984
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anupam Chem Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yashita Tripathi  | Director | 01-May-2018 | Current |
| Seema Tripathi | Director | 16-May-1998 | Current |
Financial Performance of Anupam Chem Pharma.
Anupam Chem Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 130.43% increase. The company also saw a substantial improvement in profitability, with a 188% increase in profit. The company's net worth Soared by an impressive increase of 10.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anupam Chem Pharma?
In 2022, Anupam Chem Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Narvada Developers LimitedActive 17 years 10 monthsYashita Tripathi and Seema Tripathi are mutual person
- Soundspeaks Studio Private LimitedActive 12 years 7 months
Yashita Tripathi and Seema Tripathi are mutual person
- Devkosh Traders Private LimitedActive 11 years 6 months
Yashita Tripathi and Seema Tripathi are mutual person
- Dynamic Apartments Private LimitedActive 35 years 5 months
Yashita Tripathi and Seema Tripathi are mutual person
- Taxila Welcure Private LimitedActive 16 years 10 months
Yashita Tripathi and Seema Tripathi are mutual person
Charges (Loans)
₹8.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 8.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2021 | Others | ₹8.00 Cr | Open |
How Many Employees Work at Anupam Chem Pharma?
Unlock and access historical data on people associated with Anupam Chem Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anupam Chem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anupam Chem Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
